ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,502.35
-0.73%
Dow Jones
44,424.25
-0.32%
Gold vs US Dollar
2,771.73
0.00%
Brent Oil
77.625
0.00%
Bitcoin
104,633.68
-0.09%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. XOMA Royalty Corporation (XOMAO)

  7. XOMA Royalty Corporation (XOMAO) News

XOMA Royalty (XOMAO)

XOMA Royalty Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:XOMAO
DateTimeSourceHeadlineSymbolCompany
19/12/202412:30GlobeNewswire Inc.XOMA Royalty Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAOXOMA Royalty Corporation
02/12/202412:30GlobeNewswire Inc.XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its PortfolioNASDAQ:XOMAOXOMA Royalty Corporation
07/11/202412:30GlobeNewswire Inc.XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent ActivitiesNASDAQ:XOMAOXOMA Royalty Corporation
22/10/202412:00GlobeNewswire Inc.XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist BioscienceNASDAQ:XOMAOXOMA Royalty Corporation
23/09/202410:30GlobeNewswire Inc.Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)NASDAQ:XOMAOXOMA Royalty Corporation
23/09/202409:30GlobeNewswire Inc.XOMA Royalty Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAOXOMA Royalty Corporation
04/09/202411:30GlobeNewswire Inc.XOMA Royalty to Present at Upcoming Investor Conferences in SeptemberNASDAQ:XOMAOXOMA Royalty Corporation
13/08/202411:30GlobeNewswire Inc.XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent ActivitiesNASDAQ:XOMAOXOMA Royalty Corporation
20/06/202411:30GlobeNewswire Inc.XOMA Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAOXOMA Royalty Corporation
12/06/202411:30GlobeNewswire Inc.XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review VoucherNASDAQ:XOMAOXOMA Royalty Corporation
14/05/202411:30GlobeNewswire Inc.XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQNASDAQ:XOMAOXOMA Royalty Corporation
09/05/202411:30GlobeNewswire Inc.XOMA Reports First Quarter 2024 Financial Results and Highlights Recent ActivitiesNASDAQ:XOMAOXOMA Royalty Corporation
30/04/202411:30GlobeNewswire Inc.XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%NASDAQ:XOMAOXOMA Royalty Corporation
25/04/202411:30GlobeNewswire Inc.XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)NASDAQ:XOMAOXOMA Royalty Corporation
03/04/202413:00GlobeNewswire Inc.XOMA Corporation Announces Closing of Tender OfferNASDAQ:XOMAOXOMA Royalty Corporation
21/03/202411:30GlobeNewswire Inc.XOMA Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAOXOMA Royalty Corporation
19/03/202420:05GlobeNewswire Inc.XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.NASDAQ:XOMAOXOMA Royalty Corporation
08/03/202412:30GlobeNewswire Inc.XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder ValueNASDAQ:XOMAOXOMA Royalty Corporation
28/02/202412:30GlobeNewswire Inc.XOMA to Present at Upcoming Investor Conferences in MarchNASDAQ:XOMAOXOMA Royalty Corporation
16/02/202413:00GlobeNewswire Inc.XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value RightNASDAQ:XOMAOXOMA Royalty Corporation
18/01/202413:30GlobeNewswire Inc.XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® AcquisitionNASDAQ:XOMAOXOMA Royalty Corporation
11/01/202421:05GlobeNewswire Inc.FDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRxNASDAQ:XOMAOXOMA Royalty Corporation
08/01/202412:30GlobeNewswire Inc.XOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of the Board of DirectorsNASDAQ:XOMAOXOMA Royalty Corporation
02/01/202412:30GlobeNewswire Inc.XOMA Announces Stock Repurchase Program of up to $50 MillionNASDAQ:XOMAOXOMA Royalty Corporation
20/12/202312:30GlobeNewswire Inc.XOMA Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAOXOMA Royalty Corporation
19/12/202312:30GlobeNewswire Inc.XOMA Raises up to $140 Million in Non-Dilutive, Non-Recourse Financing from Funds Managed by Blue Owl Capital Backed by VABYSMO® RoyaltiesNASDAQ:XOMAOXOMA Royalty Corporation
07/11/202312:30GlobeNewswire Inc.XOMA Reports Third Quarter 2023 Financial Results and Highlights Upcoming Events Expected to Drive Shareholder ValueNASDAQ:XOMAOXOMA Royalty Corporation
31/10/202311:30GlobeNewswire Inc.XOMA Earns $5 Million Milestone Upon FDA Acceptance of Day One’s Tovorafenib NDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)NASDAQ:XOMAOXOMA Royalty Corporation
25/09/202311:30GlobeNewswire Inc.XOMA Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAOXOMA Royalty Corporation
06/09/202311:30GlobeNewswire Inc.XOMA to Present at H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:XOMAOXOMA Royalty Corporation
 Showing the most relevant articles for your search:NASDAQ:XOMAO

Your Recent History

LSE
QBT
Quantum Blockchain Techn...
LSE
BOO
Boohoo
LSE
GKP
Gulf Keystone Petroleum
LSE
TERN
Tern
LSE
GEX
Georgina Energy
LSE
JIM
Jarvis Securities
LSE
SBTX
Skinbiotherapeutics
LSE
SCLP
Scancell
LSE
POS
Plexus
LSE
VAST
Vast Resources
LSE
PIER
Brighton Pier
LSE
LLOY
Lloyds Banking
LSE
AXL
Arrow Exploration
LSE
CARD
Card Factory
LSE
BARC
Barclays
LSE
IOF
Iofina
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads